Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies
In this on-demand recording of a live webinar, expert faculty discuss risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults.
Decera Clinical Education Infectious Disease Podcast · Barbara Resnicki PhD CRNP, Stefan Gravenstein MD MPH, Spencer H Durham PharmD BCPS BCIDP
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast, Spencer H. Durham, PharmD, BCPS, BCIDP; Stefan Gravenstein, MD, MPH; and Barbara Resnick, PhD, CRNP, discuss risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults. Following their dialogue, the faculty field questions from healthcare professionals.
Presenters:
Spencer H. Durham, PharmD, BCPS, BCIDP
Associate Clinical Professor of Pharmacy Practice
Director, Alumni & Professional Affairs Clinical Affairs & Outreach
Auburn University Harrison School of Pharmacy
Auburn, Alabama
Stefan Gravenstein, MD, MPH
Director
Division of Geriatrics and Palliative Medicine
The Warren Alpert Medical School of Brown University
Providence, Rhode Island
Barbara Resnick, PhD, CRNP
Professor
School of Nursing
University of Maryland
Nurse Practitioner
Roland Park Place
Baltimore, Maryland
Content based on an online CME program supported by educational grants from Janssen Therapeutics, Division of Janssen Products, LP.
Link to full program:
https://bit.ly/3kvr8ro
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.